25 results on '"N, Yukimatsu"'
Search Results
2. Hepatobiliary function studies on Dubin-Johnson syndrome using 99mTc-pyridoxyl-methyl-tryptophan (PMT)
- Author
-
M, Yamashita, E, Nakajima, and N, Yukimatsu
- Subjects
medicine.medical_specialty ,Pyridoxal ,Radiation ,Jaundice, Chronic Idiopathic ,business.industry ,Tryptophan ,Organotechnetium Compounds ,Middle Aged ,medicine.disease ,Gastroenterology ,Excretion ,Dubin–Johnson syndrome ,Liver ,Liver Function Tests ,Internal medicine ,Organometallic Compounds ,medicine ,Humans ,Biliary Tract ,business - Abstract
Hepatobiliary studies on five patients with Dubin-Johnson syndrome were performed using 99mTc-PMT. Time-activity curves of the liver of the patients showed delayed excretion and that plasma elimination in the patients was prolonged compared to that of normal subjects.
- Published
- 1988
3. [Angiographic findings of gallbladder cancer]
- Author
-
K, Ohno, M, Fujita, S, Akimoto, O, Satoh, K, Takahashi, K, Kushima, N, Yukimatsu, H, Matsuno, M, Nakata, and M, Yamashita
- Subjects
Aged, 80 and over ,Male ,Chronic Disease ,Angiography ,Cholecystitis ,Gallbladder ,Humans ,Female ,Gallbladder Neoplasms ,Middle Aged ,Aged - Abstract
The patients with gallbladder cancer often accompany with chronic cholecystitis. This fact leads angiographic diagnosis difficult. So the angiographic findings of the chronic cholecystitis are first analyzed precisely and subtracting the angiographic findings of the gallbladder cancer from these gives us the pure (true) angiographic findings of the gallbladder cancer. Characteristic angiographic findings of the gallbladder cancer only are stretched cystic artery encasement (27/37 cases) and short straight tumor vessels "bristly vessel" (36/37 cases).
- Published
- 1989
4. [Development of a J-shaped sheath and its usefulness for angiography]
- Author
-
M, Ohmura, T, Shimizu, N, Yukimatsu, K, Taniike, and H, Nishiguchi
- Subjects
Angiography ,Humans ,Catheterization - Abstract
We developed a new sheath for selective trans-brachial and trans-femoral arteriography. This sheath has a J-shaped tip and can be inserted by the conventional Seldinger method using a linear dilator. This sheath was particularly useful for abdominal angiography via the brachial artery and pelvic arteriography via the femoral artery.
- Published
- 1989
5. [Evaluation of ultrasonic Doppler method in ureteral disease]
- Author
-
T, Sakazaki, M, Nakata, M, Yamashita, N, Yukimatsu, and K, Murakami
- Subjects
Adult ,Male ,Ureteral Calculi ,Humans ,Ureteral Diseases ,Female ,Middle Aged ,Aged ,Ultrasonography - Published
- 1984
6. [Tuberculous abdominal mass: a case report]
- Author
-
N, Kawai, K, Taniike, M, Ohmura, N, Yukimatsu, and H, Nishiguchi
- Subjects
Granuloma ,Abdomen ,Humans ,Female ,Middle Aged ,Tuberculosis, Lymph Node - Abstract
A 64-year-old women was admitted for the examination of the abdominal mass (5 X 4.5 cm) at porta hepatis with acoustic shadow on ultrasonogram. CT demonstrated peripheral calcification of the mass compressing the portal vein. Left gastric lymph nodes were enlarged and showed ring like enhancement. Those were revealed tuberculous granulomas by the exploratory laparatomy.
- Published
- 1989
7. [A Case of Metastatic Prostate Cancer with Neuroendocrine Differentiation with Long-Term Survival after Multidisciplinary Therapy].
- Author
-
Fujita K, Kato M, Kosugi Y, Sekido Y, Matsui N, Masuda K, Yamamoto S, Matsue T, Iguchi K, Yukimatsu N, Otoshi T, Yamasaki T, Kuratsukuri K, Kohashi K, and Uchida J
- Subjects
- Male, Humans, Aged, Combined Modality Therapy, Prostatic Neoplasms, Castration-Resistant pathology, Prostatic Neoplasms, Castration-Resistant therapy, Prostatic Neoplasms, Castration-Resistant drug therapy, Time Factors, Testicular Neoplasms pathology, Testicular Neoplasms therapy, Orchiectomy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lung Neoplasms secondary, Lung Neoplasms therapy, Prostatic Neoplasms pathology, Prostatic Neoplasms therapy, Prostatic Neoplasms drug therapy
- Abstract
A 74-year-old man visited the urology clinic with the chief complaint of urinary retention in December 2014. Serum level of initial prostate specific antigen (PSA) was 50 ng/ml and he was diagnosed with Gleason Score 4+4 prostate adenocarcinoma with regional lymphadenopathy (cT3aN1M0). PSA level had declined after the treatment with combined androgen blockade. In November 2018, he was diagnosed with castration resistant prostate cancer (CRPC) as local progression was detected by computed tomography (CT) while PSA level did not increase. Since local symptoms worsened, resulting in repeated hematuria after the treatment with enzalutamide, palliative radiation therapy to the prostate (45 Gy) was performed. Five months later, follow-up CT showed multiple metastasis in bilateral lung and left testicle. Serum level of neuron-specific enolase (NSE) was 24.4 ng/ml without an elevated in serum PSA level. He received rebiopsy of the prostate, but no malignant findings were observed. Consequently, bilateral orchiectomy was performed for diagnosis of left testicular tumor. Pathological examination revealed metastasis of neuroendocrine prostate cancer (NEPC). Chemotherapy using cisplatin and irinotecan was administered after orchiectomy. Complete response of lung lesions was achieved and serum level of NSE decreased within normal range. No recurrence has been confirmed for 4 years after the completion of chemotherapy.
- Published
- 2024
- Full Text
- View/download PDF
8. Case in which percutaneous fibrin glue injection was useful for refractory urinary fistula following robot-assisted partial nephrectomy.
- Author
-
Yukimatsu N, Yamasaki T, Iguchi K, Otoshi T, Kato M, and Uchida J
- Abstract
Introduction: Urinary fistula is a rare complication following robot-assisted partial nephrectomy. For cases refractory to conservative treatment, only ureteral stent placement and percutaneous drainage are the established treatment alternatives., Case Presentation: A 44-year-old man presented with urinary fistula 3 weeks after robot-assisted partial nephrectomy for right renal cell carcinoma. Follow-up observations were conducted for 2 weeks; however, no improvements were observed. Additionally, the patient did not improve following percutaneous drainage and ureteral stent insertion. Subsequently, the patient received percutaneous injections of fibrin glue, with the urinary fistula showing significant improvements on the following day., Conclusion: Our findings indicated that percutaneous fibrin glue injection can effectively treat refractory urinary fistula following partial nephrectomy., Competing Interests: The authors declare no conflict of interest., (© 2024 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.)
- Published
- 2024
- Full Text
- View/download PDF
9. Comparison of Oncological Outcomes between Transperitoneal and Retroperitoneal Approaches in Laparoscopic Nephroureterectomies for Upper Tract Urothelial Carcinoma.
- Author
-
Otoshi T, Yamasaki T, Matsue T, Yukimatsu N, Kato M, Machida Y, Iwai T, Kuratsukuri K, and Uchida J
- Subjects
- Humans, Nephroureterectomy, Treatment Outcome, Retrospective Studies, Nephrectomy, Neoplasm Recurrence, Local surgery, Carcinoma, Transitional Cell surgery, Urinary Bladder Neoplasms, Ureteral Neoplasms pathology, Ureteral Neoplasms surgery, Laparoscopy
- Abstract
Background and Objectives : Our aim was to clarify the oncological outcomes of the two different approaches to laparoscopic nephroureterectomies (LNUs) in Japan, and to examine whether there were any significant differences between the transperitoneal approach and the retroperitoneal approach. Materials and Methods : We retrospectively evaluated patients who underwent an LNU for upper tract urothelial carcinoma (UTUC) from January 2013 to December 2022. We identified 52 patients who underwent a transperitoneal LNU (tLNU) and 93 who underwent a retroperitoneal LNU (rLNU). We adopted age, smoking, and pT-stage matching, and 43 patients were classified in each group. We investigated the time from surgery to recurrence (RFS: recurrence-free survival), the time to death (OS: overall survival), and the time to non-urothelial-tract recurrence-free survival (NUTRFS). A Cox regression analysis was performed to evaluate the risk factors that influenced recurrence. Results : There were no significant differences in the RFS, OS, and NUTRFS between the two matched groups. In the multivariate Cox regression analysis, the pT stage (pT3≥ vs. pT2≤) had an HR = 2.09 and a p = 0.01, and was an independent prognostic risk factor regarding cancer recurrence. Conclusions : There were no significant differences in the oncological outcomes between the tLNU and rLNU groups. It is suggested that the transperitoneal approach should be selected for LNUs.
- Published
- 2024
- Full Text
- View/download PDF
10. Trend in overall survival from the start of first-line chemotherapy in patients with metastatic urothelial carcinoma.
- Author
-
Yamamoto S, Kato M, Matsue T, Yukimatsu N, Takeyama Y, Otoshi T, Yamasaki T, Kuratsukuri K, and Uchida J
- Subjects
- Humans, Retrospective Studies, Carcinoma, Transitional Cell drug therapy, Urinary Bladder Neoplasms pathology, Antineoplastic Agents, Immunological therapeutic use, Immunoconjugates therapeutic use
- Abstract
New approaches involving immune checkpoint inhibitors and antibody-drug conjugates prolong overall survival in patients with metastatic urothelial carcinoma. However, the access to such systemic therapy in clinical practice is suboptimal, and whether these agents improve overall survival in patients with metastatic urothelial carcinoma over time remains unclear. Hence, we investigated the overall survival trend from the initiation of first-line therapy with these agents to identify changes due to the medication and time of treatment initiation. We retrospectively evaluated 195 patients from a single center. They were treated with chemotherapy, pembrolizumab, or avelumab or enfortumab vedotin. The treatment was categorized into chemotherapy, pembrolizumab or avelumab/enfortumab vedotin period. The new agents prolonged overall survival from the start of first-line therapy. Furthermore, sequential treatment with these agents in real-world clinical practice has been reported to prolong overall survival. These study results will have major implications when a new first-line therapy is approved in the future., (© The Author(s) 2023. Published by Oxford University Press.)
- Published
- 2024
- Full Text
- View/download PDF
11. Investigation of eligibility for adjuvant therapy from real-world data of patients with urothelial carcinoma undergoing radical cystectomy and radical nephroureterectomy.
- Author
-
Matsue T, Kato M, Kosugi Y, Ishizaki K, Masuda H, Yamamoto S, Takeyama Y, Yukimatsu N, Otoshi T, Yamasaki T, Kuratsukuri K, and Uchida J
- Subjects
- Humans, Cystectomy, Nephroureterectomy, Nivolumab, Retrospective Studies, Clinical Trials as Topic, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms pathology
- Abstract
Objective: Adjuvant nivolumab prolonged disease-free survival compared with placebo in patients at high risk of recurrence following radical cystectomy or radical nephroureterectomy in the CheckMate 274 trial. However, the ideal eligibility criteria for adjuvant therapy in real-world clinical practice remain controversial., Methods: We retrospectively analyzed clinical data of 409 patients who underwent radical cystectomy (n = 252) or radical nephroureterectomy (n = 157) and validated the risk of recurrence based on the classification used in the CheckMate 274 trial. We also investigated the impact of perioperative chemotherapy, lymph node dissection and pathological factors on prognosis., Results: The median follow-up time was 37.5 and 32.1 months in bladder cancer and upper tract urothelial carcinoma, respectively. Among the high-risk patients based on CheckMate 274 trial, disease-free survival was considerably shorter for bladder cancer and upper tract urothelial carcinoma patients than for low-risk patients (hazard ratios: 4.132 and 7.101, respectively). The prevalence of adjuvant chemotherapy in high-risk patients was low (24 and 38% for bladder cancer and upper tract urothelial carcinoma, respectively). The extent of lymph node dissection in bladder cancer and presence of lymph node dissection in upper tract urothelial carcinoma did not affect prognosis. Cox proportional multivariate analysis revealed CheckMate 274-high-risk as a poor prognostic factor in bladder cancer and upper tract urothelial carcinoma., Conclusions: This study validated the risk classification for recurrence following radical cystectomy and radical nephroureterectomy using the CheckMate 274 criteria in real-world practice. Further research would help assess the degree of benefit obtained from adjuvant nivolumab., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
12. Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.
- Author
-
Yamamoto S, Kato M, Takeyama Y, Azuma Y, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Fujioka M, Gi M, Wanibuchi H, and Uchida J
- Subjects
- Mice, Animals, Humans, CD8-Positive T-Lymphocytes, B7-H1 Antigen, Tumor Microenvironment, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms radiotherapy, Carcinoma, Transitional Cell, Myeloid-Derived Suppressor Cells
- Abstract
Background: Radiotherapy (RT) has recently been highlighted as a partner of immune checkpoint inhibitors. The advantages of RT include activation of lymphocytes while it potentially recruits immunosuppressive cells, such as myeloid-derived suppressor cells (MDSCs). This study aimed to investigate the mechanism of overcoming treatment resistance in immunologically cold tumours by combining RT and MDSC-targeted therapy., Methods: The abscopal effects of irradiation were evaluated using MB49 and cisplatin-resistant MB49R mouse bladder cancer cells, with a focus on the frequency of immune cells and programmed cell death-ligand 1 (PD-L1) expression in a xenograft model., Results: MB49R was immunologically cold compared to parental MB49 as indicated by the fewer CD8
+ T cells and lower PD-L1 expression. Polymorphonuclear MDSCs increased in both MB49 and MB49R abscopal tumours, whereas the infiltration of CD8+ T cells increased only in MB49 but not in MB49R tumours. Interestingly, PD-L1 expression was not elevated in abscopal tumours. Finally, blocking MDSC in combination with RT remarkably reduced the growth of both MB49 and MB49R abscopal tumours regardless of the changes in the frequency of infiltrating CD8+ T cells., Conclusions: The combination of RT and MDSC-targeted therapy could overcome treatment resistance in immunologically cold tumours., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
13. Response biomarkers of inhalation exposure to cigarette smoke in the mouse lung.
- Author
-
Suzuki S, Asai K, Gi M, Kojima K, Kakehashi A, Oishi Y, Matsue T, Yukimatsu N, Hirata K, Kawaguchi T, and Wanibuchi H
- Abstract
Cigarette smoking is known to increase the risk of cancer and chronic obstructive pulmonary disease (COPD). In this study, we evaluated the effects of short-term nose-only inhalation exposure to cigarette smoke in mice. Male 10-week-old C57BL mice were exposed to clean air (control) or mainstream cigarette smoke for 1 h/day, 5 days/week, for 2 or 4 weeks. Exposure to cigarette smoke increased the number of inflammatory cells, especially neutrophils, in the bronchoalveolar lavage fluid, increased inflammatory cell infiltration foci, and caused an increase in the thickness of the peripheral bronchial epithelium. Microarray gene expression analysis indicated that smoke exposure induced inflammatory responses, including leukocyte migration and activation of phagocytes and myeloid cells, as early as two weeks after the initiation of exposure. Importantly, chemokine (C-C motif) ligand 17, resistin-like alpha, and lipocalin 2 were upregulated and may serve as useful markers of the toxic effects of exposure to cigarette smoke before pulmonary histological changes become evident., (©2022 The Japanese Society of Toxicologic Pathology.)
- Published
- 2022
- Full Text
- View/download PDF
14. A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma.
- Author
-
Yamamoto S, Kato M, Takeyama Y, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Kuratsukuri K, and Uchida J
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carboplatin therapeutic use, Cisplatin therapeutic use, Female, Humans, Male, Middle Aged, Platinum therapeutic use, Retrospective Studies, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms drug therapy
- Abstract
Background: Recently, switch maintenance with avelumab has been approved for the treatment of advanced or metastatic urothelial carcinoma (UC), with no progression after four to six cycles of first-line platinum-based chemotherapy. However, the optimal number of cycles of platinum-based chemotherapy has not been determined., Objective: To analyze the clinical characteristics of patients with advanced UC who were treated with platinum-based chemotherapy and investigate the association between the number of cycles of the treatment and the patients' overall survival., Methods: A total of 124 patients with advanced UC who were treated with first-line platinum-based chemotherapy at Osaka City University Hospital between April 2009 and January 2020 were retrospectively reviewed., Results: Of the 124 patients, clinical information regarding overall survival was available for 115 patients. The median age was 72 years (range, 43-95 years). Only 59 patients (51.3 %) were treated with gemcitabine and cisplatin, and 52 patients (45.2 %) were treated with gemcitabine and carboplatin. The median number of cycles was three (1-8), and the percentage of patients who discontinued chemotherapy due to progressive disease was 80.3%, 64.0%, and 86.4% in those receiving one to three, four, and five or more cycles, respectively. Moreover, no difference in overall survival was observed between patients who received four cycles and those who received five or more cycles at both univariate and multivariate levels., Conclusions: The present study shows that five or more cycles of first-line platinum-based chemotherapy did not prolong overall survival compared with four cycles, suggesting that four cycles of chemotherapy might be sufficient, considering the new treatment strategy involving switch maintenance with avelumab., Competing Interests: Conflict of interest The authors have no conflict of interest., (Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
15. [A Case of Metastatic Urothelial Carcinoma with Pseudoprogression of Liver Metastasis during the Treatment with Pembrolizumab].
- Author
-
Masuda H, Kato M, Yoshiuchi H, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Kuratsukuri K, and Uchida J
- Subjects
- Aged, Antibodies, Monoclonal, Humanized, Cisplatin, Female, Humans, Lymphatic Metastasis drug therapy, Carcinoma, Transitional Cell drug therapy, Carcinoma, Transitional Cell surgery, Liver Neoplasms drug therapy, Liver Neoplasms secondary, Urinary Bladder Neoplasms surgery
- Abstract
A 75-year-old woman with a complaint of gross hematuria was referred to our hospital. The patient was diagnosed as having bladder cancer (cT3bN1M0) and received two cycles of chemotherapy with gemcitabine and cisplatin. Radical cystectomy with pelvic lymph node dissection and bilateral ureterostomy was performed after achieving partial response in a lymph node metastasis following chemotherapy. Based on the pathological diagnosis of high-grade (G3) urothelial carcinoma (ypT3aN2), two more cycles of adjuvant chemotherapy with gemcitabine and cisplatin were administered. Four months after completing adjuvant chemotherapy, pulmonary and hepatic metastases appeared, and treatment with pembrolizumab was initiated. The size of the lung metastasis decreased, while that of the liver metastasis increased 2 months after administering pembrolizumab. However, considering treatment beyond progression using checkpoint inhibitors, pembrolizumab was continued, resulting in marked tumor shrinkage of the liver metastasis. After that, pembrolizumab treatment was temporarily discontinued, and radiation therapy was administered for a new lymph node metastasis at the tracheal bifurcation. Eventually, the lymph node metastasis shrank, and the treatment with pembrolizumab was recommenced for 1 year and the metastases remained shrumken.
- Published
- 2022
- Full Text
- View/download PDF
16. Dimethylarsinic acid (DMA) enhanced lung carcinogenesis via histone H3K9 modification in a transplacental mouse model.
- Author
-
Fujioka M, Suzuki S, Gi M, Kakehashi A, Oishi Y, Okuno T, Yukimatsu N, and Wanibuchi H
- Subjects
- Animals, Arsenic, Carcinogens, Female, Lung, Male, Maternal-Fetal Exchange, Mice, Models, Animal, Pregnancy, Cacodylic Acid toxicity, Carcinogenesis drug effects, Histones metabolism, Lung Neoplasms
- Abstract
Pregnant CD-1 mice received 200 ppm dimethylarsinic acid (DMA) in the drinking water from gestation day 8-18, and tumor formation was assessed in offspring at the age of 84 weeks. DMA elevated the incidence of lung adenocarcinoma (10.0%) and total tumors (33.3%) in male offspring compared to male control offspring (1.9 and 15.1%, respectively). DMA also elevated the incidence of hepatocellular carcinoma (10.0%) in male offspring compared to male control offspring (0.0%). DMA and its metabolites were detected in the lungs of transplacental DMA-treated neonatal mice. Transplacental DMA exposure increased cell proliferation in the epithelium in the lungs of both neonatal and 6-week-old male mice. Microarray and real-time PCR analyses detected high expression of keratin 8 (Krt8) in the lungs of both neonatal and 6-week-old DMA-treated mice. Western blot analysis indicated that DMA elevated methylation of histone H3K9, but not H3K27, in the lungs of male mice. Importantly, chromatin immunoprecipitation sequencing (ChIP-seq) analysis using an H3K9me3 antibody found differences in heterochromatin formation between mice exposed to DMA and the controls. Notably, ChIP-seq analysis also found regions of lower heterochromatin formation in DMA-treated mice, and one of these regions contained the Krt8 gene, agreeing with the results obtained by microarray analysis. High expression of Krt8 was also detected in adenoma and adenocarcinoma of the lung in male offspring. Overall, these data indicate that transplacental DMA treatment enhanced lung and liver carcinogenesis in male mice. In the lung, DMA caused aberrant methylation of histone H3K9, increased Krt8 expression, and enhanced cell proliferation.
- Published
- 2020
- Full Text
- View/download PDF
17. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
- Author
-
Yukimatsu N, Gi M, Okuno T, Fujioka M, Suzuki S, Kakehashi A, Yanagiba Y, Suda M, Koda S, Nakatani T, and Wanibuchi H
- Subjects
- Animals, Carcinogenicity Tests, Carcinogens administration & dosage, Cyclooxygenase 2 metabolism, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Neoplastic drug effects, Male, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins c-jun metabolism, Rats, Inbred F344, Real-Time Polymerase Chain Reaction, Urinary Bladder drug effects, Urinary Bladder pathology, Urinary Bladder Neoplasms pathology, Butylhydroxybutylnitrosamine toxicity, Carcinogens toxicity, Toluidines toxicity, Urinary Bladder Neoplasms chemically induced
- Abstract
Recent epidemiological studies have indicated that occupational exposure to the aromatic amine acetoaceto-o-toluidide (AAOT) was associated with a marked increase in urinary bladder cancers in Japan. However, little is known about the carcinogenicity of AAOT. To evaluate the urinary bladder carcinogenicity of AAOT, male and female F344 rats were treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) for 4 weeks followed by dietary administration of 0, 0.167, 0.5, or 1.5% AAOT for 31 weeks. The incidences and multiplicities of bladder tumors were significantly increased in the 0.5 and 1.5% groups of male and female rats in a dose-response manner. AAOT and seven downstream metabolites were detected in the urine of the male and female rats administered AAOT with levels increasing in a dose-dependent manner. The most abundant urinary metabolite of AAOT was the human bladder carcinogen o-toluidine (OTD), which was at least one order of magnitude higher than AAOT and the other AAOT metabolites. In a second experiment, male F344 rats were administered 0, 0.167, or 1.5% AAOT for 4 weeks. Gene expression analyses revealed that the expression of JUN and its downstream target genes was increased in the urothelium of male rats treated with 1.5% AAOT. These results demonstrate that AAOT promotes BBN-induced urinary bladder carcinogenesis in rats and suggest that overexpressed of JUN and its downstream target genes may be involved the bladder carcinogenicity of AAOT. In conclusion, AAOT, like other carcinogenic aromatic amines, is likely to be a carcinogen to the urinary bladder, and OTD metabolized from AAOT is the ultimate carcinogen.
- Published
- 2019
- Full Text
- View/download PDF
18. Chronic dietary toxicity and carcinogenicity studies of dammar resin in F344 rats.
- Author
-
Gi M, Fujioka M, Yamano S, Kakehashi A, Oishi Y, Okuno T, Yukimatsu N, Yamaguchi T, Tago Y, Kitano M, Hayashi SM, and Wanibuchi H
- Subjects
- Animals, Apoptosis drug effects, Body Weight drug effects, Carcinogenicity Tests methods, Chemical and Drug Induced Liver Injury etiology, Chemical and Drug Induced Liver Injury pathology, Dose-Response Relationship, Drug, Female, Food Additives administration & dosage, Hemoglobins metabolism, Liver pathology, Liver Neoplasms chemically induced, Liver Neoplasms pathology, Male, Oxidative Stress drug effects, Rats, Rats, Inbred F344, Resins, Plant administration & dosage, Sex Factors, Toxicity Tests, Chronic methods, Toxicity Tests, Subacute methods, DNA Damage drug effects, Food Additives toxicity, Liver drug effects, Resins, Plant toxicity
- Abstract
Dammar resin is a natural food additive and flavoring substance present in many foods and drinks. The present study evaluates the chronic toxicity and carcinogenicity of dietary dammar resin in F344 rats. Dietary concentrations in the 52-week chronic toxicity study were 0, 0.03, 0.125, 0.5, or 2%. The major treatment-related deleterious effects were body weight suppression, increased relative liver weight, and low hemoglobin levels in males and females. Foci of cellular alteration in the liver were observed in the male 2% group, but not in any other group. The no-observed-adverse-effect level for chronic toxicity was 0.125% for males (200.4 mg/kg b.w./day) and females (241.9 mg/kg b.w./day). Dietary concentrations in the 104-week carcinogenicity study were 0, 0.03, 0.5, or 2%. Dammar resin induced hemorrhagic diathesis in males and females, possibly via the inhibition of extrinsic and intrinsic coagulation pathways. Incidences of hepatocellular adenomas and carcinomas were significantly increased in the male 2% group, but not in any other group. In the 4-week subacute toxicity study, the livers of male rat-fed diet-containing 2% dammar resin had increased levels of protein oxidation and increased the expression of two anti-apoptotic and seven cytochrome P450 (CYP) genes. There was also an increased tendency of oxidative DNA damage. These findings demonstrate that dammar resin is hepatocarcinogenic in male F344 rats and underlines the roles of inhibition of apoptosis, induction of CYP enzymes, and oxidative stress in dammar resin-induced hepatocarcinogenesis.
- Published
- 2018
- Full Text
- View/download PDF
19. Clinical Outcome of Elderly Kidney Transplant Recipients from Spousal Donors.
- Author
-
Iwai T, Uchida J, Kuwabara N, Kabei K, Yukimatsu N, Okamura M, Yamasaki T, Naganuma T, Kumada N, and Nakatani T
- Subjects
- ABO Blood-Group System, Aged, Blood Group Incompatibility, Cytomegalovirus Infections physiopathology, Female, Follow-Up Studies, Glomerular Filtration Rate, Graft Survival, Humans, Immunosuppression Therapy, Immunosuppressive Agents therapeutic use, Japan, Kidney pathology, Male, Middle Aged, Retrospective Studies, Spouses, Treatment Outcome, Kidney Failure, Chronic surgery, Kidney Transplantation, Living Donors
- Abstract
Introduction: Patients aged 60 years and older stand for the fastest growing group of patients with end-stage renal disease worldwide, and the need for kidney transplants among this population is rising. In Japan, living donor kidney transplantation is mainly performed to deal with the severe shortage of deceased donors, and the number of spousal transplants is currently increasing., Patients and Methods: A total of 164 patients with ESRD underwent living donor kidney transplantation at our institution, of whom 21 patients aged 60 years and older had spousal kidney transplantation. ABO-incompatible kidney transplantation was performed in 5 of the 21 cases. We analyzed these recipients., Results: Patient and graft survival rates were 100%. The incidence of acute rejection was 23.8%. Eight patients experienced cytomegalovirus viremia, two patients experienced Pneumocystis jiroveci infection, and one experienced bacterial pneumonia. Two patients developed cancers and underwent curative operation after transplantation., Conclusions: Elderly kidney transplantation from spousal donors is associated with age-related immune dysfunction, which may develop infections and malignancies and could be immunologically high risk due to the high rate of ABO-incompatibility and poor histocompatibility. An effort to minimize the adverse effect of immunosuppression and to reduce the risk of acute rejection may be needed for an excellent long-term outcome., (© 2015 S. Karger AG, Basel.)
- Published
- 2015
- Full Text
- View/download PDF
20. A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab.
- Author
-
Kanamaru T, Iguchi T, Yukimatsu N, Shimizu Y, Kohyama Y, Tachibana H, Kato M, Yamasaki T, Tamada S, and Nakatani T
- Abstract
A 68-year-old man was introduced to our hospital for the treatment of lung and mediastinum lymph node metastases that originated from an urachal carcinoma 4 years after a partial cystectomy. First-line chemotherapy with an S-1 and cisplatin combination was ineffective. The patient received FOLFIRI plus bevacizumab chemotherapy as salvage chemotherapy. Stability was achieved after eight cycles of FOLFIRI plus bevacizumab therapy. We conducted a biopsy of the metastatic tumor, and the pathology of the biopsy tissue was partially necrotic. To our knowledge, this case represents the first report of a metastatic urachal carcinoma treated with FOLFIRI plus bevacizumab.
- Published
- 2014
- Full Text
- View/download PDF
21. [Evaluation of ultrasonic Doppler method in ureteral disease].
- Author
-
Sakazaki T, Nakata M, Yamashita M, Yukimatsu N, and Murakami K
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Ureteral Calculi diagnosis, Ultrasonography, Ureteral Diseases diagnosis
- Published
- 1984
22. Hepatobiliary function studies on Dubin-Johnson syndrome using 99mTc-pyridoxyl-methyl-tryptophan (PMT).
- Author
-
Yamashita M, Nakajima E, and Yukimatsu N
- Subjects
- Humans, Middle Aged, Biliary Tract physiopathology, Jaundice, Chronic Idiopathic physiopathology, Liver physiopathology, Liver Function Tests methods, Organometallic Compounds, Organotechnetium Compounds, Pyridoxal analogs & derivatives, Tryptophan analogs & derivatives
- Abstract
Hepatobiliary studies on five patients with Dubin-Johnson syndrome were performed using 99mTc-PMT. Time-activity curves of the liver of the patients showed delayed excretion and that plasma elimination in the patients was prolonged compared to that of normal subjects.
- Published
- 1988
- Full Text
- View/download PDF
23. [Angiographic findings of gallbladder cancer].
- Author
-
Ohno K, Fujita M, Akimoto S, Satoh O, Takahashi K, Kushima K, Yukimatsu N, Matsuno H, Nakata M, and Yamashita M
- Subjects
- Aged, Aged, 80 and over, Cholecystitis complications, Chronic Disease, Female, Gallbladder Neoplasms complications, Humans, Male, Middle Aged, Angiography, Cholecystitis diagnostic imaging, Gallbladder blood supply, Gallbladder Neoplasms diagnostic imaging
- Abstract
The patients with gallbladder cancer often accompany with chronic cholecystitis. This fact leads angiographic diagnosis difficult. So the angiographic findings of the chronic cholecystitis are first analyzed precisely and subtracting the angiographic findings of the gallbladder cancer from these gives us the pure (true) angiographic findings of the gallbladder cancer. Characteristic angiographic findings of the gallbladder cancer only are stretched cystic artery encasement (27/37 cases) and short straight tumor vessels "bristly vessel" (36/37 cases).
- Published
- 1989
24. [Development of a J-shaped sheath and its usefulness for angiography].
- Author
-
Ohmura M, Shimizu T, Yukimatsu N, Taniike K, and Nishiguchi H
- Subjects
- Humans, Angiography instrumentation, Catheterization instrumentation
- Abstract
We developed a new sheath for selective trans-brachial and trans-femoral arteriography. This sheath has a J-shaped tip and can be inserted by the conventional Seldinger method using a linear dilator. This sheath was particularly useful for abdominal angiography via the brachial artery and pelvic arteriography via the femoral artery.
- Published
- 1989
25. [Tuberculous abdominal mass: a case report].
- Author
-
Kawai N, Taniike K, Ohmura M, Yukimatsu N, and Nishiguchi H
- Subjects
- Female, Granuloma diagnosis, Humans, Middle Aged, Abdomen, Tuberculosis, Lymph Node diagnosis
- Abstract
A 64-year-old women was admitted for the examination of the abdominal mass (5 X 4.5 cm) at porta hepatis with acoustic shadow on ultrasonogram. CT demonstrated peripheral calcification of the mass compressing the portal vein. Left gastric lymph nodes were enlarged and showed ring like enhancement. Those were revealed tuberculous granulomas by the exploratory laparatomy.
- Published
- 1989
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.